Table 2 Odds ratios (ORs) for hepatocellular carcinoma (HCC) associated with sequence variants in the EnhII/BCP/precore regions of hepatitis B virus*
RegionVariantHCC (n = 132) (%)Controls (n = 204) (%)OR† (95% CI)
EnhIInt 1703A109 (82.6)186 (91.2)1
G20 (15.2)7 (3.4)2.21 (1.14 to 4.28)
C3 (2.2)11 (5.4)
nt 1719G104 (78.8)193 (94.6)1
T28 (21.2)11 (5.4)4.64 (2.21 to 9.71)
nt 1726C48 (36.4)128 (62.7)1
A83 (62.9)76 (37.3)2.94 (1.86 to 4.63)
G1 (0.7)0 (0.0)
nt 1727T56 (42.4)143 (70.1)1
A50 (37.9)35 (17.2)3.21 (2.03 to 5.08)
G23 (17.4)18 (8.8)
C3 (2.3)8 (3.9)
nt 1730G60 (45.5)155 (76.0)1
C71 (53.8)48 (23.5)3.82 (2.38 to 6.12)
A1 (0.7)1 (0.5)
EnhII/BCPnt 1753T102 (77.3)181 (88.7)1
C26 (19.7)16 (7.8)2.35 (1.29 to 4.30)
A2 (1.5)2 (1.0)
G2 (1.5)4 (2.0)
Frameshift0 (0)1 (0.5)
nt 1762A52 (39.4)132 (64.7)1
T77 (58.3)69 (33.8)2.90 (1.83 to 4.60)
Deletion/frameshift3 (2.3)3 (1.5)
nt 1764G48 (36.4)131 (64.2)1
A81 (61.4)69 (33.8)3.24 (2.04 to 5.16)
T0 (0)1 (0.5)
Deletion/frameshift3 (2.2)3 (1.5)
BCPnt 1799G57 (43.2)152 (74.5)1
C69 (52.3)48 (23.5)3.92 (2.45 to 6.26)
T2 (1.5)1 (0.5)
A1 (0.7)0 (0)
Frameshift3 (2.3)3 (1.5)
PrecoreWithout start/stop codon mutation55 (41.7)66 (32.4)1
Stop codon mutation69 (52.3)121 (59.3)0.67 (0.43 to 1.06)
Start codon mutation8 (6.0)17 (8.3)
  • *For all nt positions in EnhII/BCP, the most prevalent nt type among controls were used as the reference group. For the precore region, subjects without the start/stop codon mutation were used as the reference group.

  • †OR adjusted for age at recruitment (continuous variable) and date of blood collection (continuous variable).

  • CI, confidence interval; nt, nucleotide; A, adenine; G, guanine; C, cytosine; T, thymine.